Solid organ transplantation in the HIV-infected patient

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Blumberg, E A ^a   Stock, P ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV infection; Liver transplantation; Renal transplantation

Indexed keywords

ABACAVIR; ADEFOVIR; ATAZANAVIR; ATOVAQUONE; CALCINEURIN INHIBITOR; COTRIMOXAZOLE; CYCLOSPORIN A; DAPSONE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENTECAVIR; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; INTERFERON; LAMIVUDINE; MYCOPHENOLIC ACID; NEVIRAPINE; PNEUMOCOCCUS VACCINE; PYRIMETHAMINE; RALTEGRAVIR; RAPAMYCIN; RIBAVIRIN; STAVUDINE; TENOFOVIR; WART VIRUS VACCINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ATYPICAL MYCOBACTERIOSIS; CD4+ T LYMPHOCYTE; COCCIDIOIDOMYCOSIS; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS A; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; LIVER TRANSPLANTATION; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SHORT SURVEY; TOXOPLASMOSIS; VACCINATION; VIRUS LOAD;

HIV INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; RISK FACTORS;

EID: 72949084441     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02903.x     Document Type: Short Survey

References (31)

1. Simonds RJ, Holmberg SD, Hurwitz RL et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992 326 : 726 732.
2. Ahn J, Cohen SM. Transmission of Human Immunodeficiency Virus and Hepatitis C Virus through liver transplantation. Liver Transplant 2008 14 : 1603 1608.
3. Villa E, Nanni Costa A. HIV-positive organs used for transplant in Italy due to human error. Euro Surveill 2007 12 : E070322.5
4. Stock PG, Roland ME. Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplant 2007 84 : 563 571.
5. Szczech LA, Gupta SK, Habash R et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004 66 : 1145 1152.
6. Erice A, Rharne FS, Heussner RC, Dunn DL, Balfour HH Jr. Human immunodeficiency virus infection in patients with solid-organ transplants: Report of five cases and review. Rev Infect Dis 1991 13 : 537 547.
7. Abbott KC, Swanson SJ, Agodoa LY, Kimmel PL. Human immunodeficiency virus infection and kidney transplantation in the era of highly active retroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004 15 : 1633 1639.
8. Locke JE, Montgomery RA, Warrant DS, Subramanian A, Segev DL. Renal transplant in HIV-positive patients. Arch Surg 2009 144 : 83 86.
9. Roland ME, Barin B, Carlson L et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008 8 : 355 365.
10. Stock P, Roland M, Hanto D et al. Early and unexpected results in a multicenter study of kidney transplantation in HIV-infected recipients. Am J Transplant 2009; 9(Suppl2) : 197.
11. Kumar MS, Sierka DR, Damask AM et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int 2005 67 : 1622 1629.
12. Kumar MSA, Khan SM, Ranganna K, Malat GE, Kumar AMS, Jacobson JM. In HIV +patients with end stage renal disease (ESRD) kidney transplantation significantly prolongs long-term patient survival compared to chronic dialysis treatment. Am J Transplant 2008; 8(Suppl 2) : 179.
13. Mindikoglu AL, Regev A, Magder LS. Impact of Human Immunodeficiency Virus on survival after liver transplantation: Analysis of United Network for Organ Sharing database. Transplantation 2008 85 : 359 368.
14. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with Hepatitis B virus and Human Immunodeficiency Virus infections referred for liver transplantation. Liver Transplant 2006 12 : 801 807.
15. Calabrese LH, Albrecht M, Young J et al. Successful cardiac transplantation in and HIV-1 infected patient with advanced disease. N Engl J Med 2003 348 : 2323 2328.
16. Uriel N, Jorde UP, Cotarlan V et al. Heart transplantation in human immunodeficiency virus-positive patients. J Heart Lung Transplant 2009 28 : 667 669.
17. Toso C, Berney T, Oberholzer J et al. Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient. Am J Transplant 2003 3 : 631 633.
18. Grossi PA, Donati D, Dalla Gasperina D et al. Kidney, kidney-pancreas and liver-kidney transplantation in HIV infected individuals: The Italian experience. Am J Transplant 2008 8 (Suppl 2 602.
19. De Vera ME, Vorchik I, Tom K et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent Hepatitis C. Am J Transplant 2006 6 : 2983 2993.
20. Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung JJ. Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transplant 2005 11 : 1425 1430.
21. th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada; February 2009.
22. DuClos-Vallée J-C, Féray C, Sebagh M et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008 47 : 407 417.
23. Bhagat V, Foont JA, Schiff ER, Regev A. Spontaneous clearance of Hepatitis C Virus after liver transplantation in two patients coinfected with Hepatitis C virus and human immunodeficiency virus. Liver Transplant 2008 14 : 92 95.
24. Gasser O, Bihl F, Sanghavi S et al. Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation. Am J Transplant 2009 9 : 794 803.
25. Carter JT, Melcher ML, Carlson LL, Roland ME, Stock PG. Thymoglobulin-associated CD4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients. Am JTransplant 2006 6 : 753 760.
26. Ciuffreda D, Pantaleo G, Pascual M. Effects of immunosuppressive drugs on HIV infection: Implications for solid-organ transplantation. Transplant Int 2007 20 : 649 658.
27. Margolis DM, Kewn S, Coull JJ et al. The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA. JAIDS 2002 31 : 45 49.
28. Frassetto LA, Browne M, Cheng A et al. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant 2007 7 : 2816 2820.
29. Tricot L, Teicher E, Peytavin G et al. Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant 2009 9 : 1946 1952.
30. Bani-Sadr F, Palmer P, Scieux C, Molina JM. Ninety-six week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild type hepatitis B virus. Clin Infect Dis 2004 39 : 1062 1064.
31. Kaplan JE, Benson C, Holmes KK, Brookes JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of American. MMWR 2009 58 (RR04 1 198.